Home > Healthcare > Medical Devices > Therapeutic Devices > Ophthalmic Eye Dropper Market

Ophthalmic Eye Dropper Market Size

  • Report ID: GMI8332
  • Published Date: Feb 2024
  • Report Format: PDF

Ophthalmic Eye Dropper Market Size

Ophthalmic Eye Dropper Market size was valued at USD 13.3 billion in 2023 and is estimated to grow at a CAGR of 6.3% between 2024 and 2032. Ophthalmic eye dropper, also known as an eye dropper, is a device used to deliver liquid medications or solutions into the eye. It is commonly used for various eye conditions and treatments such as dry eye disease, glaucoma, among others.

 

The increasing prevalence of various eye disorders have emerged as a significant driver for the market. For instance, according to the World Health Organization, in 2023, glaucoma ranks as the second leading cause of blindness globally, with an estimated 60 million suspected cases worldwide. Therefore, there is a rising need for effective treatments like eye drops to manage these complicated eye health issues.

Furthermore, growing technological advancements in ophthalmic drug delivery systems, rising ophthalmic ultrasound systems which is set to reach USD 1.3 billion by 2032, increasing geriatric population coupled with disease, increasing awareness and diagnosis, rising ophthalmic devices, and preference for non-invasive treatment options, among other contributing factors propelling the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of ophthalmic eye dropper reached USD 13.3 billion in 2023 and is set to witness 6.3% CAGR between 2024 and 2032, led by the rising prevalence of various eye disorders globally.

Preserved multi-dose ophthalmic eye dropper segment generated USD 6.4 billion in revenue in 2023, owing to growing preference as they have a longer shelf life compared to preservative-free single-dose units.

North America market size was USD 5.4 billion in 2023, due to the presence of a large aging population susceptible to age-related eye conditions.

Some of the leading firms engaged in the market are AbbVie Inc., Alcon plc, AptarGroup, Inc., Bausch & Lomb Incorporated, Novartis AG, PanOptica, Inc., Pfizer Inc, Sager Pharma Kft, Silgan Dispensing Systems LLC, and Similasan Corp.

Ophthalmic Eye Dropper Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 274
  • Countries covered: 22
  • Pages: 140
 Download Free Sample